Profil
Tasuku Kitada is the founder of Strand Therapeutics, Inc. where he currently holds the titles of President, Secretary & Director since 2017.
He previously worked as a Senior Analyst at Candriam Belgium SA.
Postes actifs de Tasuku Kitada
| Sociétés | Poste | Début |
|---|---|---|
Strand Therapeutics, Inc.
 Strand Therapeutics, Inc. BiotechnologyHealth Technology Strand Therapeutics, Inc. develops genetically programming mRNA therapeutics. The company was founded by Tasuku Kitada, Darrell J. Irvine, Ron Weiss, and Jacob Becraft and is headquartered in Cambridge, MA. | Fondateur | 31/10/2017 |
Anciens postes connus de Tasuku Kitada
| Sociétés | Poste | Fin |
|---|---|---|
Candriam Belgium SA
 Candriam Belgium SA Investment ManagersFinance Candriam Belgium SA (Candriam) is the Belgian asset management subsidiary of Candriam Luxembourg SCA, ultimately held by New York Life Insurance Co. in the US. Founded in 1998, the firm was formerly known as Dexia Asset Management Belgium SA, the asset management division of Dexia SA (XB: DEXB). In 2014, New York Life Investments acquired Dexia Asset Management and the firm changed their name to Candriam, which is an acronym of their core values: “Conviction and Responsibility in Asset Management”. Headquartered in Brussels, Candriam provides discretionary and non-discretionary investment advisory services to US registered funds, a limited number of US natural persons, and to institutions. | Analyst-Equity | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Candriam Belgium SA
Candriam Belgium SA Investment ManagersFinance Candriam Belgium SA (Candriam) is the Belgian asset management subsidiary of Candriam Luxembourg SCA, ultimately held by New York Life Insurance Co. in the US. Founded in 1998, the firm was formerly known as Dexia Asset Management Belgium SA, the asset management division of Dexia SA (XB: DEXB). In 2014, New York Life Investments acquired Dexia Asset Management and the firm changed their name to Candriam, which is an acronym of their core values: “Conviction and Responsibility in Asset Management”. Headquartered in Brussels, Candriam provides discretionary and non-discretionary investment advisory services to US registered funds, a limited number of US natural persons, and to institutions. | Finance |
Strand Therapeutics, Inc.
Strand Therapeutics, Inc. BiotechnologyHealth Technology Strand Therapeutics, Inc. develops genetically programming mRNA therapeutics. The company was founded by Tasuku Kitada, Darrell J. Irvine, Ron Weiss, and Jacob Becraft and is headquartered in Cambridge, MA. | Health Technology |
